Heron Therapeutics | HRTX - Marktkapitalisierung

Aktienkurs
0.80
Täglich Wechseln
0.02 2.32%
Monatlich
-26.87%
Jährlich
-67.20%
Q1 Prognose
0.76




Marktkapitalisierung Veränderung Datum
ALKERMES USD 4.47B 146M 2026-03
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amarin USD 308M 18M 2026-03
ANI Pharmaceuticals USD 1.77B 269M 2025-12
Anika Therapeutics USD 210M 71M 2026-03
Arrowhead Research USD 9.02B 4.25B 2025-12
Eisai JPY 1.4T 85.07B 2026-03
Emergent BioSolutions USD 125M 51M 2023-12
Esperion Therapeutics USD 475M 410M 2026-03
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Heron Therapeutics USD 133M 105M 2026-03
Insmed USD 37.12B 6.68B 2025-12
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Pacira USD 1.06B 94M 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Veracyte USD 3.33B 627M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12